Document:

EX-4.4

 Exhibit 4.4 

WARRANT AGREEMENT 

THIS WARRANT AGREEMENT ( “Agreement”) is made as of [●], 2020 between Golden Falcon Acquisition Corp., a
Delaware corporation, with offices at 850 Library Avenue, Suite 204, Newark, Delaware 19711 (“Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, New York, New
York 10004 (“Warrant Agent”). 
 WHEREAS, the Company is engaged in an initial public offering (“Public
Offering”) of up to 28,750,000 units, each unit (“Unit”) comprised of one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), and
one-half of one redeemable warrant, where each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment as described herein, and, in
connection therewith, will issue and deliver up to 14,375,000 warrants (the “Public Warrants”) to the public investors in connection with the Public Offering; 

WHEREAS, the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on
Form S-1, File No. 333-[●] (“Registration Statement”), and a prospectus (the “Prospectus”), for the registration, under the
Securities Act of 1933, as amended (“Securities Act”), of, among other securities, the Public Warrants; 
 WHEREAS,
the Company has received a binding commitment from Golden Falcon Sponsor Group, LLC (the “Sponsor”) to purchase redeemable warrants and, in connection therewith, will issue and deliver up to 7,750,000 redeemable warrants (the
“Private Warrants”) upon consummation of the Public Offering; 
 WHEREAS, the Company may issue up to an additional
1,500,000 redeemable warrants in satisfaction of certain working capital loans made by the Company’s officers, directors, initial stockholders (as defined in the Prospectus) and their affiliates (“Working Capital Warrants”);

 WHEREAS, following consummation of the Public Offering, the Company may issue additional warrants (“Post IPO
Warrants” and collectively with the Public Warrants, Private Warrants and Working Capital Warrants, the “Warrants”) in connection with, or following the consummation by the Company of, a Business Combination (defined
below); 
 WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so
act, in connection with the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; 
 WHEREAS, the
Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of
the Warrants; and 
 WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when
executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding, and legal obligations of the Company, and to authorize the execution and delivery
of this Agreement. 
 NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as
follows: 
 1.    Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for
the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement. 

  
 1 

	2.	 Warrants. 

2.1    Form of Warrant. Each Warrant shall be issued in registered form only and, subject to Section 2.2, shall
be in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board of Directors, the Chief Executive Officer, the Chief
Financial Officer, the Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before
such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 

2.2    Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant, or portion thereof,
may be issued as part of, and be represented by, a Unit, and any Warrant may be issued in uncertificated or book-entry form through the Warrant Agent and/or the facilities of The Depository Trust Company (the “Depositary”) or other
book-entry depositary system, in each case as determined by the Board of Directors of the Company or by an authorized committee thereof. Any Warrant so issued shall have the same terms, force and effect as a certificated Warrant that has been duly
countersigned by the Warrant Agent in accordance with the terms of this Agreement. 
 2.3    Effect of
Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the
holder thereof. 
 2.4    Registration. 

2.4.1    Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the
registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such
denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected through,
records maintained by institutions that have accounts with the Depositary. 
 If the Depositary subsequently ceases to make its book-entry
settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary
to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the
Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants which shall be in the form annexed hereto as Exhibit A. 

2.4.2    Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and
the Warrant Agent may deem and treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”) as the absolute owner of such Warrant and of each Warrant represented thereby
(notwithstanding any notation of ownership or other writing on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the
Warrant Agent shall be affected by any notice to the contrary. 
 2.5    Detachability of Warrants. The
securities comprising the Units will not be separately transferable until the 52nd day following the date of the Prospectus or, if such 52nd
day is not on a day, other than Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or
earlier with the consent of UBS Securities LLC and Moelis & Co., the representatives (the “Representatives”) of the several underwriters of the Public Offering, but in no event shall the securities comprising the Units be
separately traded earlier unless (i) the Company has filed a Current Report on Form 8-K with the SEC which 

  
 2 

 
includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Public Offering including the proceeds received by the Company from the exercise of the
underwriters’ option to purchase additional Units in the Public Offering, if such option is exercised prior to the filing of the Form 8-K, and (ii) the Company has issued a press release announcing
when such separate trading shall begin (the “Detachment Date”). 
 2.6    Private Warrant and
Working Capital Warrant Attributes. The Private Warrants and Working Capital Warrants shall be identical to the Public Warrants, except that, so long as they are held by the initial recipients thereof or any of their Permitted Transferees (as
defined below), (i) such Warrants shall not be redeemable by the Company pursuant to Section 6.1.1 hereof, (ii) such Warrants may be exercised for cash or on a cashless basis at the holder’s option pursuant to Section 3.3.1(c)
hereof and (iii) such Warrants shall be subject to the transfer restrictions contained in Section 5.6 hereof. Once a Private Warrant or Working Capital Warrant is transferred to a holder other than to a Permitted Transferee, it shall be
treated as a Public Warrant hereunder for all purposes. 
 2.7    Post IPO Warrants. The Post IPO Warrants, when
and if issued, shall have the same terms and be in the same form as the Public Warrants except as may be agreed upon by the Company. 

2.8    Fractional Warrants. The Company shall not issue fractional Warrants other than as part of the Units, each
of which is comprised of one share of Common Stock and one-half of one redeemable Public Warrant. If, upon the detachment of Public Warrants from the Units or otherwise, a holder of Warrants would be entitled
to receive a fractional Warrant, the Company shall round up to the nearest whole number the number of Warrants to be issued to such holder. 
  

	3.	 Terms and Exercise of Warrants.  

3.1    Warrant Price. Each whole Warrant shall, when countersigned by the Warrant Agent (if certificated in
physical form), entitle the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to
the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to the price per share at which the shares of Common Stock may be
purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days; provided, that the
Company shall provide at least three (3) days prior written notice of such reduction to registered holders of the Warrants and, provided further that any such reduction shall be applied consistently to all of the Warrants. 

3.2    Duration of Warrants. A Warrant may be exercised only during the period commencing on the later of thirty
(30) days from the date the Company completes a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities (“Business
Combination”) (as described more fully in the Registration Statement) and twelve (12) months from the date of the closing of the Public Offering, and terminating on the earlier to occur of (i) at 5:00 p.m., New York City time on
the date that is five years from the date the Company consummates its initial Business Combination, (ii) other than with respect to the Private Warrants and Working Capital Warrants then held by the initial recipients thereof or their
respective Permitted Transferees with respect to a redemption pursuant to Section 6.1.1 hereof (an “Inapplicable Redemption”), at 5:00 p.m., New York City time on the Redemption Date, as provided in Section 6.2 of this
Agreement and (iii) the liquidation of the Company (“Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in
subsection 3.3.2 below, with respect to an effective registration statement or a valid exemption therefrom being available. The period of time from the date the Warrants will first become exercisable until the expiration of the Warrants shall
hereafter be referred to as the “Exercise Period.” Except with respect to the right to receive the $18.00 Redemption Price or the $10.00 Redemption Price (as set forth in Section 6 hereunder), as applicable (other than with
respect to an Inapplicable Redemption), each Warrant (other than a Private Warrant or Working Capital Warrant in the event of an 

  
 3 

 
Inapplicable Redemption) not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00
p.m., New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that the Company shall provide at least twenty (20) days prior
written notice of any such extension to registered holders and, provided further that any such extension shall be applied consistently to all of the Warrants. 

3.3    Exercise of Warrants. 

3.3.1    Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the
Warrant Agent (if certificated in physical form), may be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in the Borough of Manhattan, City and
State of New York (or, in the case of a Warrant represented by a book-entry, the Warrants to be exercised on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant
Agent to the Depositary from time to time), with the subscription form, as set forth in the Warrant, duly executed (or, in the case of a Warrant represented by a book-entry, properly delivered by the Participant in accordance with the
Depositary’s procedures), and by paying in full the Warrant Price for each share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, as follows: 

(a)    in lawful money of the United States, by good certified check or good bank draft payable to the
order of the Warrant Agent or wire transfer; or 
 (b)    in the event of redemption pursuant to
Section 6.1.1 hereof in which the Company’s management has elected to require all holders of Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of Common Stock
equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value” (defined below) over the Warrant Price by
(y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted unless the Fair Market Value is equal to or higher than the Warrant Price. Solely for purposes of this Section 3.3.1(b) and Section 6.1.2, the
“Fair Market Value” shall mean the average last reported sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of the
Warrants pursuant to Section 6 hereof; or 
 (c)    with respect to any Private Warrants or Working
Capital Warrants, so long as such Private Warrants or Working Capital Warrants are held by the initial recipients or their Permitted Transferees, by surrendering such Private Warrants or Working Capital Warrants for that number of shares of Common
Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the “Private Warrant Fair Market Value” (defined below) over the
Warrant Price by (y) the Private Warrant Fair Market Value; provided, however, that no cashless exercise shall be permitted unless the Private Warrant Fair Market Value is equal to or higher than the Warrant Price. Solely for purposes of this
Section 3.3.1(c), the “Private Warrant Fair Market Value” shall mean the average last reported sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the
notice of exercise is sent to the Warrant Agent; or 
 (d)    at any time beginning on the sixty-first
(61st) Business Day after the closing of the Company’s initial Business Combination if the registration statement required by Section 7.4 hereof is not then effective and current, by surrendering such Warrants for that number of shares of
Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the Warrant Price over the “Fair Market Value” by (y) the
Fair Market Value; provided, however, that no cashless exercise shall be permitted unless the Fair Market Value is equal to or higher than the Warrant Price. Solely for 

  
 4 

 
purposes of this Section 3.3.1(d), the “Fair Market Value” shall mean the average reported last sale price of the Common Stock for the ten (10) trading days ending on
the trading day prior to the date of exercise; or 
 (e)    as provided in Section 7.5; or 

(f)    as provided in Section 6.1.2. 

3.3.2    Issuance of Shares of Common Stock. As soon as practicable after the exercise of any Warrant and the
clearance of the funds in payment of the Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates, or book entry position, as applicable, for the number of shares of Common Stock to which
he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant, or book entry position, as applicable, for the number of shares
as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, in no event will the Company be required to net cash settle the Warrant exercise. Notwithstanding the foregoing, the Company shall not be obligated to deliver any
shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock underlying the
Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its obligations under Section 7.4 or a valid exemption from registration being available. No Warrant shall be exercisable for cash
and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the
state of residence of the registered holder of the Warrants. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a
“cashless basis,” the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round up to the nearest whole number, the number of
shares of Common Stock to be issued to such holder. Warrants may not be exercised by, or securities issued to, any registered holder in any state in which such exercise or issuance would be unlawful. 

3.3.3    Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with
this Agreement shall be validly issued, fully paid and nonassessable. 
 3.3.4    Date of Issuance. Each person
in whose name any book entry position or certificate for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant, or book entry position representing such
Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share
transfer books of the Company or book entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the share transfer books or book
entry system are open. 
 3.3.5    Maximum Percentage. A holder of a Warrant may notify the Company in writing in
the event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a
holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such
person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 4.8% or 9.8% (or such other amount as a holder may specify) (the “Maximum Percentage”) of the shares of Common Stock
outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common
Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the
Warrant beneficially 

  
 5 

 
owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and
its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in
determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Annual Report on Form
10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC as the case may be,
(2) a more recent public announcement by the Company or (3) any other notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written
request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common
Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written
notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be
effective until the sixty-first (61st) day after such notice is delivered to the Company. 
  

	4.	 Adjustments. 

4.1    Stock Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6
below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split up of shares of Common Stock, or other similar event, then, on the effective date of such stock dividend, split
up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in outstanding shares of Common Stock. A rights offering to holders of the Common Stock entitling
holders to purchase shares of Common Stock at a price less than the “Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares
of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for the Common Stock) and (ii) one (1) minus the quotient of (x) the
price per share of Common Stock paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in
determining the price payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means
the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable
market, regular way, without the right to receive such rights. 
 4.2    Aggregation of Shares. If after the date
hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation,
combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock. 

4.3    Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall
pay a dividend or make a distribution in cash, securities or other assets to the holders of the shares of Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital stock into which the Warrants are
convertible) (an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined
by the Company’s Board of Directors, in good 

  
 6 

 
faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend; provided, however, that none of the following shall be deemed an
Extraordinary Dividend for purposes of this provision: (a) any adjustment described in subsection 4.1 above, (b) any cash dividends or cash distributions which, when combined on a per share basis with the per-share amount of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or
distribution to the extent it does not exceed $0.50 (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to
the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant), (c) any payment to satisfy the redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination,
(d) any payment to satisfy the redemption rights of the holders of the Common Stock in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing
of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or in connection with certain amendments to the Company’s Amended and Restated Certificate of Incorporation prior thereto or
to redeem 100% of the shares of Common Stock included in the Units sold in the Offering if the Company has not completed its initial Business Combination within the time period set forth in the Company’s Amended and Restated Certificate of
Incorporation or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, or (e) any payment in connection with the redemption of
the shares of Common Stock included in the Units sold in the Offering upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation. Solely for purposes of
illustration, if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 and previously paid an aggregate of $0.40 of cash dividends and cash distributions on the Common Stock during the 365-day period ending on the date of declaration of such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately after the effective date of such $0.35 dividend, by $0.25 (the absolute
value of the difference between $0.75 (the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater of (x) $0.50
and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35 dividend)). 

4.4    Adjustments in Exercise Price. 

4.4.1    Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as
provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares
of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter. 

4.4.2    If (i) the Company issues additional shares of Common Stock or equity-linked securities for capital raising
purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (as adjusted for stock splits, stock dividends, rights issuances, subdivisions,
reorganizations, recapitalizations and the like), with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any
founder shares (as defined in the Prospectus) held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (ii) the aggregate gross proceeds from such issuances represent more than 60%
of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation thereof (net of redemptions) and (iii) the volume weighted average trading price of the Common
Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share (as adjusted for stock
splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price
and the $10.00 Redemption Trigger Price and $18.00 Redemption Trigger Price shall be adjusted (to the nearest cent) to equal to 100% and 180% of the greater of the Market Value and the Newly Issued Price, respectively. 

  
 7 

 4.5    Replacement of Securities upon Reorganization, etc. In
case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change covered by Section 4.1, 4.2 or 4.3 hereof or that solely affects the par value of the Common Stock), or in the case of any merger or
consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Common
Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Warrant holders
shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the
exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any
such sale or transfer, that the Warrant holder would have received if such Warrant holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided, that if less than 70% of the
consideration receivable by the holders of the Common Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within
thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be
reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the
Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped
American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be
the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day
volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury
rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of
Common Stock, and (ii) in all other cases, the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any
reclassification also results in a change in the Common Stock covered by Section 4.1, 4.2 or 4.3, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3, 4.4 and this Section 4.5. The provisions of this Section 4.5
shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

 4.6    Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares
issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares
purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3, 4.4
or 4.5, then, in any such event, the Company shall give written notice to each Warrant holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice,
or any defect therein, shall not affect the legality or validity of such event. 

  
 8 

 4.7    No Fractional Warrants or Shares. Notwithstanding any
provision contained in this Agreement to the contrary, the Company shall not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon
the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round up to the nearest whole number of shares of Common Stock to be issued to the Warrant holder. 

4.8    Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this
Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant to this Agreement. However, the Company may at any time in its sole
discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding
Warrant or otherwise, may be in the form as so changed. 
 4.9    Other Events. In case any event shall occur
affecting the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the
Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing,
which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of
such adjustment; provided, however, that under no circumstances shall the Warrants be adjusted pursuant to this Section 4.9 as a result of any issuance of securities in connection with a Business Combination. The Company shall adjust the terms
of the Warrants in a manner that is consistent with any adjustment recommended in such opinion. 
 4.10    No
Adjustment. For the avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an adjustment to the conversion ratio of the Class B common stock of the Company (the “Class B
Common Stock”) into Common Stock or the conversion of the Class B Common Stock into Common Stock, in each case, pursuant to the Company’s amended and restated certificate of incorporation, as amended from time to time. 

 

	5.	 Transfer and Exchange of Warrants. 

5.1    Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any
outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures, in the case of certificated Warrants, properly guaranteed and accompanied by appropriate instructions for transfer. Upon
any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by
the Warrant Agent to the Company from time to time upon request. 
 5.2    Procedure for Surrender of Warrants.
Warrants may be surrendered to the Warrant Agent, either in certificated form or in book entry position, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new
Warrants, in certificate form or book entry positions, as requested by the registered holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for
transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and
indicating whether the new Warrants must also bear a restrictive legend. 

  
 9 

 5.3    Fractional Warrants. The Warrant Agent shall not be
required to effect any registration of transfer or exchange which will result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units. 

5.4    Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 5.5    Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to
deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly
executed on behalf of the Company for such purpose. 
 5.6    Private Warrants and Working Capital Warrants. The
Warrant Agent shall not register any transfer of Private Warrants or Working Capital Warrants until 30 days after the consummation by the Company of an initial Business Combination, except (a) to the Company’s initial stockholders (as
defined in the Prospectus), officers, directors or advisors, any affiliates or family members of any of the Company’s initial stockholders, officers, directors or advisors or any affiliate of the Company’s initial stockholders, officers,
directors or advisors, (b) in the case of an individual, transfers by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such
person, or to a charitable organization; (c) in the case of an individual, transfers by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, transfers pursuant to a qualified domestic
relations order; (e) transfers by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than the price at which the Warrants were originally purchased; (f) transfers in the event
of the Company’s liquidation prior to the completion of its initial Business Combination; (g) in the case of an entity, transfers by virtue of the laws of its jurisdiction or operating agreement upon dissolution; (h) to the Company
for no value for cancellation in connection with the consummation of an initial Business Combination; or (i) in the event of the Company’s liquidation, merger, capital stock exchange, reorganization or other similar transaction which
results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property subsequent to our completion of the Company’s initial Business Combination; provided, however,
that in the case of clauses (a) through (g) these permitted transferees (the “Permitted Transferees”) must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained
in the letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and the Company’s directors and officers and by the same agreements entered into by the Sponsor with respect to such securities (including provisions
relating to voting, the trust account and liquidation distributions described in the Prospectus). 
 5.7    Transfers
prior to Detachment. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or
exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.7 shall have
no effect on any transfer of Warrants on or after the Detachment Date. 
  

	6.	 Redemption. 

6.1    Redemption. Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be
redeemed, at the option of the Company, as follows: 
 6.1.1    Redemption when the Price Per Share of Common Stock
Equals or Exceeds $18.00. The Company may redeem all of the outstanding Warrants at any time during the Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (the
“$18.00 Redemption Price”), provided that the last reported sales price of the Common Stock equals or exceeds $18.00 per share (subject to adjustment in accordance with Section 4 hereof) (the “$18.00 Redemption 

  
 10 

 
Trigger Price”), on each of twenty (20) trading days within any thirty (30) trading day period commencing after the Warrants become exercisable and ending on the third
trading day prior to the date on which notice of redemption is given and provided that there is an effective registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus
relating thereto, available throughout the 30-day redemption period or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to
subsection 3.3.1(b). 
 6.1.2    Redemption when the Price Per Share of Common Stock Equals or Exceeds
$10.00. The Company may redeem all of the outstanding Warrants at any time following 90 days after the commencement of the Exercise Period, at the office of the Warrant Agent, upon the notice pursuant to Section 6.2, at the price of $0.10
per Warrant (the “$10.00 Redemption Price”), if and only if (i) the last reported sales price of the Common Stock equals or exceeds $10.00 per share (subject to adjustment in accordance with Section 4 hereof) (the
“$10.00 Redemption Trigger Price”), on the trading day prior to the date on which notice of redemption is given, (ii) the Private Warrants and Working Capital Warrants, if any, are also concurrently called for redemption on the
same terms as described in this Section 6, and (iii) there is an effective registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the Warrants and a current prospectus relating thereto
available throughout the thirty (30) day period after written notice of redemption is given (the “Redemption Period”). During the Redemption Period in connection with a redemption pursuant to this Section 6.1.2, registered
holders of the Warrants may elect to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of shares of the Company’s Common Stock to be determined by reference to the table below,
based on the Redemption Date (calculated for purposes of the table as the period to expiration of the Warrants) and the “Fair Market Value” of the Company’s Common Stock (as defined in Section 3.3.1(b)). 

 

																																					
	 Redemption Date (period to 
expiration of
warrants)
	  	Fair Market Value of Class A Common Stock	 
	  	£$10.00	 	  	$11.00	 	  	$12.00	 	  	$13.00	 	  	$14.00	 	  	$15.00	 	  	$16.00	 	  	$17.00	 	  	3$18.00	 
	 57 months
	  	 	0.233	 	  	 	0.255	 	  	 	0.275	 	  	 	0.293	 	  	 	0.309	 	  	 	0.324	 	  	 	0.338	 	  	 	0.350	 	  	 	0.361	 
	 54 months
	  	 	0.229	 	  	 	0.251	 	  	 	0.272	 	  	 	0.291	 	  	 	0.307	 	  	 	0.323	 	  	 	0.337	 	  	 	0.350	 	  	 	0.361	 
	 51 months
	  	 	0.225	 	  	 	0.248	 	  	 	0.269	 	  	 	0.288	 	  	 	0.305	 	  	 	0.321	 	  	 	0.336	 	  	 	0.349	 	  	 	0.361	 
	 48 months
	  	 	0.220	 	  	 	0.243	 	  	 	0.265	 	  	 	0.285	 	  	 	0.303	 	  	 	0.320	 	  	 	0.335	 	  	 	0.349	 	  	 	0.361	 
	 45 months
	  	 	0.214	 	  	 	0.239	 	  	 	0.261	 	  	 	0.282	 	  	 	0.301	 	  	 	0.318	 	  	 	0.334	 	  	 	0.348	 	  	 	0.361	 
	 42 months
	  	 	0.208	 	  	 	0.234	 	  	 	0.257	 	  	 	0.278	 	  	 	0.298	 	  	 	0.316	 	  	 	0.333	 	  	 	0.348	 	  	 	0.361	 
	 39 months
	  	 	0.202	 	  	 	0.228	 	  	 	0.252	 	  	 	0.275	 	  	 	0.295	 	  	 	0.314	 	  	 	0.331	 	  	 	0.347	 	  	 	0.361	 
	 36 months
	  	 	0.195	 	  	 	0.222	 	  	 	0.247	 	  	 	0.271	 	  	 	0.292	 	  	 	0.312	 	  	 	0.330	 	  	 	0.346	 	  	 	0.361	 
	 33 months
	  	 	0.187	 	  	 	0.215	 	  	 	0.241	 	  	 	0.266	 	  	 	0.288	 	  	 	0.309	 	  	 	0.328	 	  	 	0.345	 	  	 	0.361	 
	 30 months
	  	 	0.179	 	  	 	0.208	 	  	 	0.235	 	  	 	0.261	 	  	 	0.284	 	  	 	0.306	 	  	 	0.326	 	  	 	0.345	 	  	 	0.361	 
	 27 months
	  	 	0.170	 	  	 	0.199	 	  	 	0.228	 	  	 	0.255	 	  	 	0.280	 	  	 	0.303	 	  	 	0.324	 	  	 	0.343	 	  	 	0.361	 
	 24 months
	  	 	0.159	 	  	 	0.190	 	  	 	0.220	 	  	 	0.248	 	  	 	0.274	 	  	 	0.299	 	  	 	0.322	 	  	 	0.342	 	  	 	0.361	 
	 21 months
	  	 	0.148	 	  	 	0.179	 	  	 	0.210	 	  	 	0.240	 	  	 	0.268	 	  	 	0.295	 	  	 	0.319	 	  	 	0.341	 	  	 	0.361	 
	 18 months
	  	 	0.135	 	  	 	0.167	 	  	 	0.200	 	  	 	0.231	 	  	 	0.261	 	  	 	0.289	 	  	 	0.315	 	  	 	0.339	 	  	 	0.361	 
	 15 months
	  	 	0.120	 	  	 	0.153	 	  	 	0.187	 	  	 	0.220	 	  	 	0.253	 	  	 	0.283	 	  	 	0.311	 	  	 	0.337	 	  	 	0.361	 
	 12 months
	  	 	0.103	 	  	 	0.137	 	  	 	0.172	 	  	 	0.207	 	  	 	0.242	 	  	 	0.275	 	  	 	0.306	 	  	 	0.335	 	  	 	0.361	 
	 9 months
	  	 	0.083	 	  	 	0.117	 	  	 	0.153	 	  	 	0.191	 	  	 	0.229	 	  	 	0.266	 	  	 	0.300	 	  	 	0.332	 	  	 	0.361	 
	 6 months
	  	 	0.059	 	  	 	0.092	 	  	 	0.130	 	  	 	0.171	 	  	 	0.213	 	  	 	0.254	 	  	 	0.292	 	  	 	0.328	 	  	 	0.361	 
	 3 months
	  	 	0.030	 	  	 	0.060	 	  	 	0.100	 	  	 	0.145	 	  	 	0.193	 	  	 	0.240	 	  	 	0.284	 	  	 	0.324	 	  	 	0.361	 
	 0 months
	  	 	0.000	 	  	 	0.000	 	  	 	0.042	 	  	 	0.115	 	  	 	0.179	 	  	 	0.233	 	  	 	0.281	 	  	 	0.324	 	  	 	0.361	 

  
 11 

 The exact Fair Market Value and Redemption Date may not be set forth in the table above, in which case, if
the Fair Market Value is between two values in the table or the Redemption Date is between two redemption dates in the table, the number of shares of Common Stock to be issued for each Warrant exercised will be determined by a straight-line
interpolation between the number of shares set forth for the higher and lower Fair Market Values and the earlier and later Redemption Dates, as applicable, based on a 365 or 366-day year, as applicable. 

The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of
a Warrant is adjusted pursuant to Section 4. The adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares
deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the
same manner and at the same time as the number of shares issuable upon exercise of a Warrant. In no event will the number of shares issued in connection with a Make-Whole Exercise exceed 0.365 shares of Common Stock per Warrant (subject to
adjustment). 
 6.2    Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem
all of the Warrants that are subject to redemption pursuant to Section 6.1, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by
the Company not less than thirty (30) days prior to the Redemption Date to the registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein
provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice. 

6.3    Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless
basis” in accordance with Section 6.1.2 of this Agreement or Section 3.3.1(b) of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the
Redemption Date. In the event the Company determines to require all holders of Public Warrants to exercise their Warrants on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information
necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the “Fair Market Value” in such case. On and after the Redemption Date, the record holder of the Warrants shall have
no further rights except to receive, upon surrender of the Warrants, the Redemption Price. 
 6.4    Exclusion of
Certain Warrants. The Company agrees that the redemption rights provided in this Section 6 (excluding Section 6.1.2) shall not apply to (i) the Private Warrants and Working Capital Warrants if at the time of the redemption such
Private Warrants or Working Capital Warrants continue to be held by the initial recipients or their Permitted Transferees or (ii) Post IPO Warrants if such warrants provide that they are non-redeemable by
the Company. However, with respect to the Private Warrants or Working Capital Warrants, once such Private Warrants or Working Capital Warrants are transferred (other than to Permitted Transferees under Section 5.6), the Company may redeem the
Private Warrants and Working Capital Warrants in the same manner as the Public Warrants. 
  

	7.	 Other Provisions Relating to Rights of Holders of Warrants. 

7.1    No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a
stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders
or the election of directors of the Company or any other matter. 
 7.2    Lost, Stolen, Mutilated, or Destroyed
Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may 

  
 12 

 
in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost,
stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone. 

7.3    Reservation of Shares of Common Stock. The Company shall at all times reserve and keep available a number of
its authorized but unissued shares of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 

7.4    Registration of Shares of Common Stock. The Company agrees that as soon as practicable, but in no event
later than fifteen (15) Business Days, after the closing of its initial Business Combination, it shall use its reasonable best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the issuance
of the shares of Common Stock issuable upon exercise of the Warrants. The Company shall use its reasonable best efforts to cause the same to become effective within sixty (60) Business Days after the closing of its initial Business Combination,
and to maintain the effectiveness of such registration statement until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the Business
Combination and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable
upon exercise of the Warrants, to exercise such Warrants on a “cashless basis” as determined in accordance with Section 3.3.1(d). The Company shall, upon request by the Warrant Agent, provide the Warrant Agent with an opinion
of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this Section 7.4 is not required to be registered under the
Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under U.S. federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any
successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in Section 7.5, for the avoidance of any doubt, unless and until all of the Warrants have been exercised, the Company shall
continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4. 

7.5    Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant
not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor rule), the Company may, at its option, (i) require
holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as described in subsection 7.4
and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable upon exercise of the
Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its best efforts to register or qualify for sale the Common Stock issuable upon exercise of the Public Warrants under the blue sky laws of the state of residence
of the exercising Public Warrant holder to the extent an exemption is not available. 
  

	8.	 Concerning the Warrant Agent and Other Matters. 

8.1    Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed
upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares. 

  
 13 

 8.2    Resignation, Consolidation, or Merger of Warrant Agent.

 8.2.1    Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter
appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or
incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in
writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the
State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing
under the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or
examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally
named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such
successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing
for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations. 

8.2.2    Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company
shall give notice thereof to the predecessor Warrant Agent and the Company’s transfer agent for the Common Stock not later than the effective date of any such appointment. 

8.2.3    Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or
with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act. 

8.3    Fees and Expenses of Warrant Agent. 

8.3.1    Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such
Warrant Agent hereunder and shall reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder. 

8.3.2    Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be
performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement. 

8.4    Liability of Warrant Agent.  

8.4.1    Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant
Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically
prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Chairman of the Board of Directors or Secretary of the Company and delivered to the Warrant Agent. The
Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement. 

  
 14 

 8.4.2    Indemnity. The Warrant Agent shall be liable hereunder
only for its own fraud, gross negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant Agent’s fraud, gross
negligence, willful misconduct or bad faith. 
 8.4.3    Exclusions. The Warrant Agent shall have no
responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of
the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this
Agreement or any Warrant or as to whether any shares of Common Stock will, when issued, be valid and fully paid and nonassessable. 

8.5    Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees
to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the
Warrant Agent for the purchase of shares of Common Stock through the exercise of Warrants. 
  

	9.	 Miscellaneous Provisions. 

9.1    Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the
Warrant Agent shall bind and inure to the benefit of their respective successors and assigns. 
 9.2    Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by
certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 

Golden Falcon Acquisition Corp. 

[    ] 

Attn: [    ] 
 Any notice,
statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified
mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows: 

Continental Stock Transfer & Trust Company 

1 State Street 
 New York, New
York 10004 
 Attn: Compliance Department 

  
 15 

 with a copy in each case to: 

Greenberg Traurig, LLP 
 1750
Tysons Boulevard 
 Suite 1000 

McLean, VA 22102 
 Attn: Alan I.
Annex, Esq. and Jason T. Simon, Esq. 
 and 

UBS Securities LLC 
 11 Wall
Street 
 New York, New York 10005 

Attn: General Counsel 
 and 

Moelis & Co. 
 399 Park
Avenue, 5th Floor 
 New York, New York 10022 

Attn: General Counsel 
 and 

Graubard Miller 
 The Chrysler
Building 
 405 Lexington Avenue 

New York, New York 10174 
 Attn:
David Alan Miller, Esq. and Jeffrey M. Gallant, Esq. 
 9.3    Applicable Law. The validity, interpretation, and
performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another
jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement may be brought and enforced in the courts of the State of New York or the United States District Court
for the Southern District of New York, and irrevocably submits to such jurisdiction (which jurisdiction shall be non-exclusive). The Company hereby waives any objection that such courts represent an inconvenient forum. Any such process or summons to
be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed
personal service and shall be legal and binding upon the Company in any action, proceeding or claim. 

9.4    Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be
implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the registered holders of the Warrants and, for the purposes of Sections 7.4,
9.4 and 9.8 hereof, the Representatives, any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. The Representatives shall be deemed to be third-party beneficiaries
of this Agreement with respect to Sections 7.4, 9.4 and 9.8 hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto (and the
Representatives with respect to the Sections 7.4, 9.4 and 9.8 hereof) and their successors and assigns and of the registered holders of the Warrants. 

9.5    Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at
the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant for inspection by it. 

9.6    Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of
such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

  
 16 

 9.7    Effect of Headings. The section headings herein are
for convenience only and are not part of this Agreement and shall not affect the interpretation thereof. 

9.8    Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder
(i) for the purpose of curing any ambiguity or to correct any mistake including to conform the provisions hereof to the description of the terms of the Warrants and this Agreement set forth in the Prospectus, or of curing, correcting or
supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not
adversely affect the interest of the registered holders and (ii) to provide for the delivery of Alternative Issuance pursuant to Section 4.4. All other modifications or amendments, including any modification or amendment to increase the
Warrant Price or shorten the Exercise Period, shall require the written consent or vote of the registered holders of at least 50% of the then outstanding Public Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or
extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the registered holders. 

9.9    Trust Account Waiver. The Warrant Agent acknowledges and agrees that it shall not make any claims or proceed
against the trust account established by the Company in connection with the Public Offering (as more fully described in the Registration Statement) (“Trust Account”), including by way of
set-off, and shall not be entitled to any funds in the Trust Account under any circumstance. In the event that the Warrant Agent has a claim against the Company under this Agreement, the Warrant Agent will
pursue such claim solely against the Company and not against the property held in the Trust Account. 

9.10    Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term
or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall
be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

[Signature Page Follows] 

  
 17 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of
the day and year first above written. 
  

			
	GOLDEN FALCON ACQUISITION CORP.
		
	By:	 	  

		 	Name: Makram Azar
		 	Title: Chief Executive Officer
	
	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Warrant Agreement]Exhibit 10.1

 

Form
of SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT is entered into
this 8th day of December, 2020 (this “Subscription Agreement”), by and between Vesper Healthcare Acquisition
Corp., a Delaware corporation (the “Company”), and the undersigned (“Subscriber”).

 

WHEREAS, the Company concurrently herewith
is entering into that certain Agreement and Plan of Merger, dated as of the date hereof, substantially in the form provided to
Subscriber (the “Merger Agreement”), pursuant to which the Company will acquire LCP Edge Intermediate, Inc.,
on the terms and subject to the conditions set forth therein (the “Transactions”);

 

WHEREAS, in connection with the Transactions,
Subscriber desires to subscribe for and purchase from the Company that number of shares of the Company’s Class A common stock,
par value $0.0001 per share (the “Class A Common Stock”) set forth on the signature page hereto (the “Acquired
Shares”), for a purchase price of $10.00 per share (the “Per Share Price”), and the aggregate purchase
price set forth on the signature page hereto (the “Purchase Price”), and the Company desires to issue and sell
to Subscriber the Acquired Shares in consideration of the payment of the Purchase Price by or on behalf of Subscriber to the Company
on or prior to the closing of the Subscription (as defined below) contemplated hereby (the “Closing”); and

 

WHEREAS, in connection with the Transactions,
certain other institutional “accredited investors” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the
Securities Act of 1933, as amended (the “Securities Act”), or otherwise within the meaning of Rule 501 under
the Securities Act and acceptable to the Company and the Placement Agent) (the “Other Subscribers”), have entered
into subscription agreements with the Company substantially similar to this Subscription Agreement (the “Other Subscription
Agreements”), pursuant to which such Other Subscribers have agreed to subscribe for and purchase, and the Company has
agreed to issue and sell to such Other Subscribers, on the Closing Date (as defined below), inclusive of the shares of Class A
Common Stock to be purchased by Subscriber hereunder, an aggregate amount of 35,000,000 shares of Class A Common Stock at the Per
Share Price, with an aggregate purchase price, inclusive of the Purchase Price hereunder, of $350,000,000.

 

NOW, THEREFORE, in consideration of the
foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending
to be legally bound hereby, the parties hereto hereby agree as follows:

 

1. Subscription. Subject to
the terms and conditions hereof, Subscriber hereby agrees to subscribe for and purchase, and the Company hereby agrees to issue
and sell to Subscriber, upon the payment of the Purchase Price by Subscriber, the Acquired Shares (such subscription and issuance,
the “Subscription”).

 

     

     

    

 

2. Closing.

 

(a) At least five (5) business days before
the anticipated closing date of the Transactions (the “Closing Date”), the Company shall deliver written notice
to Subscriber (the “Closing Notice”) specifying (i) the anticipated Closing Date and (ii) the wire instructions
for delivery of the Purchase Price to the Company. No later than two (2) business days after receiving the Closing Notice, Subscriber
shall deliver to the Company such information as is reasonably requested in the Closing Notice in order for the Company to issue
the Acquired Shares to Subscriber. Subscriber shall deliver to the Company, on or prior to 5:00 p.m. (Eastern time) (or as soon
as practicable after the Company or its transfer agent (the “Transfer Agent”) delivers evidence of the issuance
to Subscriber of the Acquired Shares on and as of the Closing Date) on the Closing Date the Purchase Price in cash via wire transfer
to the account specified in the Closing Notice against (and concurrently with) delivery by the Company to Subscriber of (i) written
notice from the Transfer Agent evidencing the issuance to Subscriber of the Acquired Shares on and as of the Closing Date, and
(ii) the Acquired Shares in book entry form, free and clear of any liens or other restrictions (other than those arising under
state or federal securities laws), in the name of Subscriber (or its nominee in accordance with its delivery instructions) or to
a custodian designated by Subscriber, as applicable. Each book entry for the Acquired Shares shall contain a notation in substantially
the following form:

 

THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER
JURISDICTION, AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM.

 

In the event that the consummation of the
Transactions does not occur within one (1) business day after the anticipated Closing Date specified in the Closing Notice, the
Company shall promptly (but in no event later than two (2) business days after the anticipated Closing Date specified in the Closing
Notice) return the funds so delivered by Subscriber to the Company by wire transfer in immediately available funds to the account
specified by Subscriber. For the avoidance of doubt, unless this Subscription Agreement has been terminated in accordance with
its terms, the return of any Purchase Price in connection with a delay in the Closing Date shall not relieve Subscriber of its
obligations to pay the Purchase Price on the date set forth in a revised Closing Notice and to otherwise comply with the terms
and conditions of this Subscription Agreement.

 

(b) The obligations of Subscriber and
the Company to consummate the purchase and sale of the Acquired Shares pursuant to this Subscription Agreement shall be subject
to the conditions that, on the Closing Date:

 

(i) no governmental authority shall
have enacted, issued, promulgated, enforced or entered any judgment, order, rule or regulation which is then in effect and has
the effect of making consummation of the transactions contemplated hereby illegal or otherwise prohibiting or enjoining consummation
of the transactions contemplated hereby; and no such governmental authority shall have instituted or threatened in writing a proceeding
seeking to impose any such prohibition or injunction; and

 

(ii) all conditions precedent to the
closing of the Transactions set forth in the Merger Agreement, including the approval of the Company’s stockholders and regulatory
approvals, if any, shall have been satisfied, as determined by the parties to the Merger Agreement and other than those conditions
under the Merger Agreement which, by their nature, are to be satisfied at the closing of the Transactions (it being understood
that, for the purpose of determining whether any such condition has been satisfied, the consummation of the purchase and sale of
the Acquired Shares pursuant to this Subscription Agreement shall be treated as having occurred), or waived, and the closing of
the Transactions shall be scheduled to occur on the Closing Date concurrently with or immediately following the Closing.

 

    2

     

    

 

(c) In addition to the conditions set
forth in Section 2(a) and Section 2(b), the obligation of the Company to consummate the issuance and sale of the Acquired Shares
pursuant to this Subscription Agreement shall be subject to the condition that all representations and warranties of Subscriber
contained in this Subscription Agreement are true and correct in all material respects (other than those representations and warranties
that are qualified as to materiality or material adverse effect, which representations and warranties shall be true in all respects)
at and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier
date, in which case, as of such earlier date) and consummation of the Closing shall constitute a reaffirmation by Subscriber of
each of the representations and warranties of Subscriber contained in this Subscription Agreement as of the Closing Date or as
of such earlier date, as applicable.

 

(d) In addition to the conditions set
forth in Section 2(a) and Section 2(b), the obligation of Subscriber to consummate the purchase of the Acquired Shares pursuant
to this Subscription Agreement shall be subject to the following conditions:

 

(i) all representations and warranties
of the Company contained in this Subscription Agreement are true and correct in all material respects (other than those representations
and warranties that are qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true
in all respects) at and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks
as of an earlier date, in which case, as of such earlier date); and consummation of the Closing shall constitute a reaffirmation
by the Company of each of the representations and warranties of the Company contained in this Subscription Agreement as of the
Closing Date or as of such earlier date, as applicable;

 

(ii) the Company shall have performed,
satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement
to have been performed, satisfied or complied with by it at or prior to Closing;

 

(iii) no amendment or modification
of the Merger Agreement (as the same exists on the date hereof as provided to Subscriber) shall have occurred that would reasonably
be expected to materially and adversely affect the economic benefits that Subscriber would reasonably expect to receive under this
Subscription Agreement, unless Subscriber has previously consented in writing to such amendment or modification;

 

(iv) there shall have been no amendment,
waiver or modification to the Other Subscription Agreements that materially economically benefits the Other Subscribers thereunder
unless the Subscriber has been offered substantially the same benefits;

 

(v) the Class A Common Stock (I) shall
be designated for quotation or listed on the Nasdaq Capital Market (“Nasdaq”) and (II) shall not have been suspended,
as of the applicable Closing Date, by the U.S. Securities and Exchange Commission (the “SEC”) or Nasdaq from
trading on Nasdaq nor shall suspension by the SEC or Nasdaq have been threatened, as of the Closing Date, either (A) in writing
by the SEC or Nasdaq or (B) by falling below the minimum listing maintenance requirements of Nasdaq; and

 

    3

     

    

 

(vi) there shall not have occurred
a “Material Adverse Effect,” as such term is defined in the Merger Agreement, with respect to LCP Edge Intermediate,
Inc. since the date hereof.

 

(e)  At the Closing, the parties hereto
shall execute and deliver such additional documents and take such additional actions as the parties reasonably may deem to be practical
and necessary in order to consummate the Subscription as contemplated by this Subscription Agreement.

 

(f) For purposes of this Subscription
Agreement, “business day” shall mean a day, other than a Saturday or Sunday, on which commercial banks in New York,
New York are open for the general transaction of business.

 

3. Company Representations and Warranties.
The Company represents and warrants to Subscriber that:

 

(a) The Company has been duly incorporated
and is validly existing as a corporation in good standing under the laws of the State of Delaware, with corporate power and authority
to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform
its obligations under this Subscription Agreement.

 

(b) The Acquired Shares have been duly
authorized by the Company and, when issued and delivered to Subscriber against full payment therefor in accordance with the terms
of this Subscription Agreement and registered with the Transfer Agent, the Acquired Shares will be validly issued, fully paid and
non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights created under the Company’s
amended and restated certificate of incorporation, the Company’s bylaws or under the Delaware General Corporation Law.

 

(c) This Subscription Agreement has been
duly authorized, executed and delivered by the Company and this Subscription Agreement constitutes a legal, valid and binding obligation
of the Company and is enforceable against the Company in accordance with its terms, except as may be limited or otherwise affected
by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights
of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

(d) The issued and outstanding shares
of Class A Common Stock are registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and are listed for trading on Nasdaq. There is no suit, action, proceeding or investigation pending or, to the
knowledge of the Company, threatened against the Company by Nasdaq or the SEC, respectively, to prohibit or terminate the listing
of the Class A Common Stock or to deregister the shares of Class A Common Stock. The Company has taken no action that is designed
to terminate the listing of the Class A Common Stock on Nasdaq or the registration of the Class A Common Stock under the Exchange
Act.

 

    4

     

    

 

(e) The execution, delivery and performance
of this Subscription Agreement, including the issuance and sale of the Acquired Shares hereunder, and the compliance by the Company
with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated herein will not
(i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result
in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or any of its
subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement
or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is
bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, which would reasonably be
expected to have a material adverse effect on the business, properties, assets, liabilities, operations, financial condition, stockholders’
equity or results of operations of the Company and its subsidiaries, taken as a whole (a “Material Adverse Effect”)
or materially affect the validity of the Acquired Shares or the legal authority of the Company to comply in all material respects
with the terms of this Subscription Agreement; (ii) result in any violation of the provisions of the organizational documents of
the Company or any of its subsidiaries; or (iii) result in any violation of any statute or any judgment, order, rule or regulation
of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its subsidiaries
or any of their respective properties that would reasonably be expected to have a Material Adverse Effect or materially affect
the validity of the Acquired Shares or the legal authority of the Company to comply in all material respects with this Subscription
Agreement.

 

(f) Assuming the accuracy of the representations
and warranties of Subscriber set forth in Section 4 and the accuracy of the Other Subscribers’ representations and warranties
set forth in the Other Subscription Agreements, the Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the Company
of this Subscription Agreement (including, without limitation, the issuance of the Acquired Shares), other than (i) the filing
with the SEC of the Registration Statement (as defined below), (ii) the filings required by applicable state or federal securities
laws, (iii) the filings required in accordance with Section 9(p), (iv) any filings or notices required by Nasdaq, (v) those required
to consummate the Transactions as provided under the Merger Agreement, and (vi) any consent, waiver, authorization or order of,
notice to, or filing or registration, the failure of which to obtain would not be reasonably expected to have, individually or
in the aggregate, a Material Adverse Effect.

 

(g) As of the date hereof, (i) the authorized
capital stock of the Company consists of (a) 200,000,000 shares of Class A Common Stock (of which 46,000,000 shares are issued
and outstanding, and all of which are validly issued, fully paid and non-assessable), (b) 20,000,000 shares of Class B common
stock, par value $0.0001 (“Class B Common Stock”) (of which 11,500,000 shares are issued and outstanding, and
all of which are validly issued, fully paid and non-assessable), and (c) 1,000,000 shares of blank check preferred stock, par value
$0.0001 (of which none are issued or outstanding), and (ii) 24,666,666 shares of Class A Common Stock are issuable in respect of
redeemable public warrants to purchase Class A Common Stock and private placement warrants to purchase Class A Common Stock. No
shares of capital stock of the Company are held in the treasury of the Company. All outstanding warrants have been duly authorized
and validly issued and are not subject to preemptive rights. Except as set forth above and pursuant to the Other Subscription Agreements,
the Merger Agreement and the other agreements and arrangements referred to therein or in the SEC Reports (as defined below), as
of the date hereof, there are no options, warrants or other rights, agreements, arrangements or commitments of any character relating
to the issued or unissued capital stock of the Company or obligating the Company to issue or sell any shares of capital stock of,
or other equity interests in, the Company. As of the date hereof, the Company has no direct or indirect subsidiaries, and does
not own or hold the right to acquire any stock, partnership interest or joint venture interest or other equity ownership interest
in any other partnership, corporation, organization or entity, other than direct ownership of Hydrate Merger Sub I, Inc. and Hydrate
Merger Sub II, LLC, and there are no outstanding contractual obligations of the Company to provide funds to, or make any investment
(in the form of a loan, capital contribution or otherwise) in, any other person. There are there are no outstanding proxies, voting
agreements or other agreements or arrangements relating to any equity securities of the Company, other than (1) as set forth in
the SEC Reports and (2) as contemplated by the Merger Agreement. There are no securities or instruments issued by or to which the
Company is a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Acquired Shares
or (ii) the shares of Class A Common Stock to be issued pursuant to any Other Subscription Agreement, that have not been or will
not be validly waived on or prior to the Closing Date.

 

    5

     

    

 

(h) Except for such matters as have not
had or would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, there is no (i) action,
suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of the Company,
threatened against the Company or (ii) judgment, decree, injunction, ruling or order of any governmental entity outstanding against
the Company.

 

(i) The Company is in compliance with
all applicable laws, except where such non-compliance would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect. The Company has not received any written communication from a governmental entity that alleges that
the Company is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default
or violation would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.

 

(j) As of their
respective dates, all forms, reports, statements, schedules, proxies, registration statements and other documents, including any
exhibits thereto, together with any amendments, restatements or supplements thereto filed by the Company with the SEC prior to
the date of this Subscription Agreement (the “SEC Reports”) were prepared in all material respects in accordance
with the requirements of the Securities Act, the Exchange Act and the rules and regulations of the SEC promulgated thereunder,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The financial statements of the Company included in the SEC Reports were prepared in all material
respects in accordance with the (i) U.S generally accepted accounting principles and (ii) Regulation S-X or Regulation S-K, as
applicable, as in effect at the time of filing and fairly present in all material respects the financial position of the Company
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case
of interim financial statements, to normal recurring year-end audit adjustments (the effect of which will not, individually or
in the aggregate, be material) and the omission of notes to the extent permitted by Regulation S-X or Regulation S-K, as applicable.
There are no outstanding or unresolved comments in comment letters received by the Company from the staff of the Division of Corporation
Finance of the SEC with respect to any of the SEC Reports.

 

(k) Other than the Other Subscription
Agreements and the Merger Agreement, the Company has not entered into any side letter or similar agreement with any other investor
in connection with such other investor’s direct or indirect investment in the Company. No Other Subscription Agreement includes
terms and conditions that are materially more advantageous to any such other investor than Subscriber hereunder, and such Other
Subscription Agreements have not been amended or modified in any material respect following the date of this Subscription Agreement.

 

(l) The Company has not entered into
any agreement or arrangement entitling any agent, broker, investment banker, financial advisor or other person to any broker’s
or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this Subscription
Agreement for which Subscriber could become liable. Other than compensation paid to Goldman Sachs & Co. LLC acting as placement
agent (the “Placement Agent”), the Company is not aware of any person that has been or will be paid (directly
or indirectly) remuneration for solicitation of purchasers in connection with the sale of any shares of Class A Common Stock hereunder
or pursuant to the Other Subscription Agreements.

 

(m) The Company is not an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.

 

(n) Neither the Company nor any of its
subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency, reorganization,
receivership, liquidation, administration or winding up or failed to pay its debts when due, nor does the Company or any subsidiary
have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings
or seek to commence an administration.

 

    6

     

    

 

(o) Except for discussions specifically
regarding the offer and sale of the Acquired Shares, the Company confirms that neither it nor any other person acting on its behalf
has provided Subscriber or its agents or counsel with any information that constitutes or could reasonably be expected to constitute
material, nonpublic information concerning the Company or any of its subsidiaries, other than with respect to the Transactions
and the transactions contemplated by this Subscription Agreement or the Other Subscription Agreements. Except with respect to the
Transactions and the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements, no event or
circumstance has occurred which, under applicable law, rule or regulation, requires public disclosure at or before the date hereof
or announcement by the Company but which has not been so publicly disclosed.

 

(p) Assuming the
accuracy of Subscriber’s representations and warranties set forth in Section 4 herein and those of the Other Subscriber
set forth in the Other Subscription Agreements, in connection with the offer, sale and delivery of the Acquired Shares in the
manner contemplated by this Subscription Agreement, (a) it is not necessary to register the Acquired Shares under the Securities
Act, (b) the Acquired Shares were not offered by any form of general solicitation or general advertising and (c) the Acquired
Shares are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities
Act or any state securities laws.

 

4. Subscriber Representations and
Warranties. Subscriber represents and warrants to the Company that:

 

(a) If Subscriber is not an individual,
Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of
incorporation or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription
Agreement. If Subscriber is an individual, Subscriber has the authority to enter into, deliver and perform its obligations under
this Subscription Agreement.

 

(b) If Subscriber is not an individual,
this Subscription Agreement has been duly authorized, executed and delivered by Subscriber. If Subscriber is an individual, the
signature on this Subscription Agreement is genuine, and Subscriber has legal competence and capacity to execute the same. This
Subscription Agreement constitutes a legal, valid and binding obligation of Subscriber, enforceable against Subscriber in accordance
with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered
at law or equity.

 

(c) The execution, delivery and performance
by Subscriber of this Subscription Agreement are within the powers of Subscriber, have been duly authorized and will not constitute
or result in a breach or default under or conflict with (i) any order, ruling or regulation of any court or other tribunal or of
any governmental commission or agency, or any agreement or other undertaking, to which Subscriber is a party or by which Subscriber
is bound, which would reasonably be expected to have a material adverse effect on the legal authority of Subscriber to comply in
all material respects with the terms of this Subscription Agreement and (ii) if Subscriber is not an individual, will not violate
any provisions of Subscriber’s organizational documents, including, without limitation, its incorporation or formation papers,
bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement
is genuine, and the signatory, if Subscriber is an individual, has legal competence and capacity to execute the same or, if Subscriber
is not an individual, the signatory has been duly authorized to execute the same.

 

    7

     

    

 

(d) Subscriber
(i) (a) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (“Rule 144A”)),
(b) is an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) satisfying
the applicable requirements set forth on Schedule A, or (c) subject to the consent of the Placement Agent, is an “accredited
investor” (within the meaning of Rule 501(a)(12) under the Securities Act) with assets under management in excess of $50,000,000
satisfying the applicable requirements set forth on Schedule A, (ii) is acquiring the Acquired Shares only for its own account
and not for the account of others, or if Subscriber is subscribing for the Acquired Shares as a fiduciary or agent for one or
more investor accounts, each owner of such account is a “qualified institutional buyer” and Subscriber has full investment
discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and
agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Acquired Shares with a view to,
or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested
information on Schedule A following the signature page hereto). Subscriber is not an entity formed for the specific purpose
of acquiring the Acquired Shares. Subscriber is an “institutional account” as defined in FINRA Rule 4512(c).

 

(e) Subscriber understands that the Acquired
Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act and that the
Acquired Shares have not been registered under the Securities Act. Subscriber understands that the Acquired Shares may not be resold,
transferred, pledged or otherwise disposed of by Subscriber absent an effective registration statement under the Securities Act,
except (i) to the Company or a subsidiary thereof, (ii) in an offshore transaction within the meaning of Regulation S under the
Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and
that any certificates representing the Acquired Shares shall contain a legend to such effect. Subscriber understands and agrees
that the Acquired Shares will be subject to transfer restrictions and, as a result of these transfer restrictions, Subscriber may
not be able to readily resell the Acquired Shares and may be required to bear the financial risk of an investment in the Acquired
Shares for an indefinite period of time. Subscriber acknowledges that the Acquired Shares will not be eligible for resale pursuant
to Rule 144A promulgated under the Securities Act. Subscriber understands that it has been advised to consult legal counsel prior
to making any offer, resale, pledge or transfer of any of the Acquired Shares.

 

(f) Subscriber understands and agrees
that Subscriber is purchasing the Acquired Shares directly from the Company. Subscriber further acknowledges that there have been
no representations, warranties, covenants and agreements made to Subscriber by (i) Placement Agent or its affiliates or any of
their respective control persons, officers, directors or employees or (ii) the Company or its affiliates or any of their respective
officers or directors, expressly or by implication, other than those representations, warranties, covenants and agreements included
in this Subscription Agreement.

 

(g) Subscriber’s acquisition and
holding of the Acquired Shares will not constitute or result in a non-exempt prohibited transaction under Section 406 of the Employee
Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended, or any applicable
similar law.

 

(h) In making its decision to subscribe
for and purchase the Acquired Shares, Subscriber has relied solely upon independent investigation made by Subscriber and has not
relied on any statements or other information provided by the Placement Agent, any of its affiliates or any of their respective
control persons, officers, directors or employees concerning the Company, LCP Edge Intermediate, Inc., their respective affiliates,
the Transactions or the Acquired Shares. Subscriber acknowledges and agrees that Subscriber has had access to, and an adequate
opportunity to review, such financial and other information as Subscriber deems necessary in order to make an investment decision
with respect to the Acquired Shares, including with respect to the Company, LCP Edge Intermediate, Inc. and the Transactions. Subscriber
and Subscriber’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers
and obtain such information as Subscriber and such undersigned’s professional advisor(s), if any, have deemed necessary to
make an investment decision with respect to the Acquired Shares. Subscriber is not relying upon, and has not relied upon, any statement,
representation or warranty made by any person, including, without limitation, the Placement Agent, except for the statements, representations
and warranties contained in this Subscription Agreement.

 

    8

     

    

 

(i) Subscriber became aware of this offering
of the Acquired Shares solely by means of contact from the Placement Agent and the Acquired Shares were offered to Subscriber solely
by contact between Subscriber and the Placement Agent. Subscriber did not become aware of this offering of the Acquired Shares,
nor were the Acquired Shares offered to Subscriber, by any other means, and BLS Investor Group LLC or its affiliates did not act
as investment adviser, broker or dealer to Subscriber. Subscriber acknowledges that the Company represents and warrants that the
Acquired Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered
in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities
laws.

 

(j) Subscriber acknowledges that it is
aware that there are substantial risks incident to the purchase and ownership of the Acquired Shares. Subscriber has such knowledge
and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Acquired
Shares, and Subscriber has sought such accounting, legal and tax advice as Subscriber has considered necessary to make an informed
investment decision.

 

(k) Alone, or together with any professional
advisor(s), Subscriber has adequately analyzed and fully considered the risks of an investment in the Acquired Shares and determined
that the Acquired Shares are a suitable investment for Subscriber and that Subscriber is able at this time and in the foreseeable
future to bear the economic risk of a total loss of Subscriber’s investment in the Company. Subscriber acknowledges specifically
that a possibility of total loss exists.

 

(l) Subscriber understands and agrees
that no federal or state agency has passed upon or endorsed the merits of the offering of the Acquired Shares or made any findings
or determination as to the fairness of this investment.

 

(m) Subscriber
is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the President
of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited by any OFAC sanctions
program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a non-U.S.
shell bank or providing banking services indirectly to a non-U.S. shell bank. Subscriber agrees to provide law enforcement agencies,
if requested thereby, such records as required by applicable law, provided that Subscriber is permitted to do so under applicable
law. Subscriber represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.)
(the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing
regulations (collectively, the “BSA/PATRIOT Act”), that Subscriber maintains policies and procedures reasonably
designed to comply with applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required,
it maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs,
including the OFAC List. To the extent required, Subscriber maintains policies and procedures reasonably designed to ensure that
the funds held by Subscriber and used to purchase the Acquired Shares were legally derived. 

 

(n) Subscriber will have at the Closing
sufficient funds to pay the Purchase Price pursuant to Section 2(a).

 

5. Additional Subscriber Agreement.
Subscriber hereby agrees that, from the date of this Subscription Agreement until the earlier of the Closing or the termination
of this Subscription Agreement in accordance with its terms, none of Subscriber or any person or entity acting on behalf of Subscriber
or pursuant to any understanding with Subscriber will engage in any Short Sales with respect to securities of the Company prior
to the Closing. For purposes of this Section 5, “Short Sales” shall include, without limitation, all “short
sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect
stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts,
options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through
non-U.S. broker dealers or foreign regulated brokers. Notwithstanding the foregoing, (i) nothing herein shall prohibit other entities
under common management with Subscriber that have no knowledge of this Subscription Agreement or of Subscriber’s participation
in the Transactions (including Subscriber’s controlled affiliates and/or affiliates) from entering into any Short Sales and
(ii) in the case of a Subscriber that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Subscriber’s assets and the portfolio managers have no knowledge of the investment decisions made by the
portfolio managers managing other portions of such Subscriber’s assets, the representation set forth above shall only apply
with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Acquired
Shares covered by this Subscription Agreement. The Company represents and warrants to the Subscriber that each of the Other Subscribers
is bound by an agreement pursuant to the Other Subscription Agreements that is substantially identical to this Section 5.

 

    9

     

    

 

6. Registration Rights.

 

(a) The Company
agrees that, within thirty (30) calendar days after the consummation of the Transactions (the “Filing Deadline”),
the Company will file with the SEC (at the Company’s sole cost and expense) a registration statement to register under and
in accordance with the provisions of the Securities Act, the resale of all Registrable Securities (as defined below) on Form S-3
(which shall be filed pursuant to Rule 415 under the Securities Act as a secondary-only registration statement), if the Company
is then eligible for such short form, or any similar or successor short form registration or, if the Company is not then eligible
for such short form registration, on Form S-1 or any similar or successor long form registration (the “Registration Statement”).
The Company will provide a draft of the Registration Statement to Subscriber for review at least three (3) business days in advance
of filing the Registration Statement, and shall advise Subscriber upon the Registration Statement being declared effective by
the SEC. In no event shall Subscriber be identified as a statutory underwriter in the Registration Statement without Subscriber’s
prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing,
if the SEC or applicable law or SEC guidance prevents the Company from including any or all of the shares proposed to be registered
under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Acquired
Shares by the applicable stockholders, such Registration Statement shall register for resale such number of Acquired Shares which
is equal to the maximum number of Acquired Shares that can be so registered. In such event, the number of Acquired Shares to be
registered for each selling stockholder named in the Registration Statement shall be reduced pro rata among all such selling shareholders.
The Company shall use its commercially reasonable efforts to have the Registration Statement declared effective by the SEC as
soon as practicable after the filing thereof, but no later than the earlier of (i) sixty (60) calendar days following the Filing
Deadline (or ninety (90) calendar days after the Filing Deadline if the Registration Statement is reviewed by and receives comments
from the SEC) and (ii) the 10th business day after the date the Company is notified (orally or in writing, whichever
is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further comments
from the SEC (such earlier date, the “Effectiveness Deadline”); provided, that the Company’s obligations
to include the Acquired Shares in the Registration Statement are contingent upon Subscriber furnishing in writing to the Company
such information regarding Subscriber, the securities of the Company held by Subscriber and the intended method of disposition
of the Acquired Shares as shall be reasonably requested by the Company to effect the registration of the Acquired Shares, and
shall execute such documents in connection with such registration as the Company may reasonably request that are customary of
a selling stockholder in similar situations, provided that Subscriber shall not in connection with the foregoing be required
to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer
the Acquired Shares. “Registrable Securities” shall mean, as of any date of determination, the Acquired Shares
and any other equity security of the Company issued or issuable with respect to the Acquired Shares by way of share split, dividend,
distribution, recapitalization, merger, exchange, replacement or similar event or otherwise, provided that, as to any particular
Registrable Securities, once issued, such securities shall cease to be Registrable Securities (i) when they are sold, transferred,
disposed or exchanged pursuant to an effective Registration Statement under the Securities Act, (ii) the earliest of (A) three
(3) years, (B) such time that such holder has disposed such securities pursuant to Rule 144 under the Securities Act (“Rule
144”) or (C) if Rule 144(i) is no longer applicable to the Company or Rule 144(i)(2) is amended to remove the current
reporting requirement preceding a disposition of securities, such time that such holder is able to dispose of all of its, his
or her Registrable Securities pursuant to Rule 144 without any volume or manner of sale limitations thereunder, (iii) when they
shall have ceased to be outstanding or (iv) when such securities have been sold in a private transaction in which the transferor’s
rights under this Section 6(a) are not assigned to the transferee of such securities. Any failure by the Company to file the Registration
Statement by the Filing Deadline or for the Registration Statement to be declared effective by the Effectiveness Deadline shall
not otherwise relieve the Company of its obligations to file or effect the Registration Statement as set forth in this Section
6.

 

(b) In the case of the registration,
qualification, exemption or compliance effected by the Company pursuant to this Section 6, the Company shall, upon reasonable request,
inform Subscriber as to the status of such registration, qualification, exemption and compliance. At its expense, the Company shall:

 

(i) except for such times as the Company
is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use its commercially reasonable
efforts to keep such registration, and any qualification, exemption or compliance under state securities laws that the Company
determines to obtain in connection with such registration, continuously effective with respect to Subscriber, and to keep the applicable
Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until all
securities acquired by Subscriber hereunder cease to be Registrable Securities or such shorter period upon which Subscriber has
notified the Company that such Registrable Securities have actually been sold;

 

    10

     

    

 

(ii) advise Subscriber within five
(5) business days:

 

(1) of the issuance by the SEC of any
stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings by the SEC for such
purpose;

 

(2) of the receipt by the Company of
any notification with respect to the suspension of the qualification of the Acquired Shares included therein for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose; and

 

(3) subject to the provisions in this
Subscription Agreement, of the occurrence of any event that requires the making of any changes in any Registration Statement or
prospectus included therein so that, as of such date, the statements therein are not misleading and do not omit to state a material
fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the
circumstances under which they were made) not misleading.

 

Notwithstanding anything
to the contrary set forth herein, the Company shall not, when so advising Subscriber of such events, provide Subscriber with any
material, nonpublic information regarding the Company other than to the extent that providing notice to Subscriber of the occurrence
of the events in the immediately preceding sentence constitutes material, nonpublic information regarding the Company;

 

(iii) use its
commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as soon as reasonably practicable;

 

(iv) upon the occurrence of any event
that requires the making of any changes in any Registration Statement or prospectus included therein so that, as of such date,
the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to
make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading,
except for such times as the Company is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part
of a Registration Statement, the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare
a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other required
document so that, as thereafter delivered to purchasers of the Acquired Shares included therein, such prospectus will not include
any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading;

  

(v) use its commercially reasonable
efforts to cause all Acquired Shares to be listed on each securities exchange or market, if any, on which the Class A Common Stock
has been listed;

 

(vi) use its commercially reasonable
efforts (1) to take all other steps necessary to effect the registration of the Acquired Shares contemplated hereby and (2) for
so long as Subscriber holds Acquired Shares, to file all reports and other materials required to be filed by the Exchange Act so
long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the
applicable provisions of Rule 144 to enable Subscriber to sell the Acquired Shares under Rule 144;

 

(vii) furnish to Subscriber, so long
as Subscriber owns Acquired Shares, promptly upon request, (1) a written statement by the Company, if true, that it has complied
with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (2) a copy of the most recent annual or quarterly
report of the Company and such other reports and documents so filed by the Company and (3) such other information as may be reasonably
requested to permit Subscriber to sell such securities pursuant to Rule 144 without registration; and

 

(viii) use its commercially reasonable
efforts to (1) cause the removal of all restrictive legends from any Acquired Shares (x) being sold under the Registration Statement;
(y) being sold pursuant to Rule 144 at the time of sale of such Registrable Securities and, at the request of a holder, cause the
removal of all restrictive legends from any Registrable Securities held by such holder that may be sold by such holder without
restriction under Rule 144, including without limitation, any volume and manner of sale restrictions, and (z) as to which such
holder provides the Company with an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such
sale, assignment or transfer of the Acquired Shares may be made without registration under the applicable requirements of the Securities
Act; and (2) in the case of subclauses (1)(x) or (y), cause its legal counsel to deliver the necessary legal opinions, if any,
to the transfer agent in connection with the instruction under subclause (1) upon the receipt of such supporting documentation,
if any, as reasonably requested by such counsel.

 

    11

     

    

 

(c) Notwithstanding anything to the contrary
in this Subscription Agreement, the Company shall be entitled to delay or postpone the effectiveness of the Registration Statement,
and from time to time to require Subscriber not to sell under the Registration Statement or to suspend the effectiveness thereof,
if the Company determines, upon advice of legal counsel, that in order for the Registration Statement to not contain a material
misstatement or omission, an amendment thereto would be needed to include information that would at that time not otherwise be
required in a current, quarterly, or annual report under the Exchange Act, or if the Company’s Board of Directors, upon advice
of legal counsel, reasonably believes that such filing or use could materially affect a bona fide business or financing transaction
of the Company or its subsidiaries or would require additional disclosure by the Company in the Registration Statement of material
information that the Company has a bona fide business purpose for keeping confidential (each such circumstance, a “Suspension
Event”); provided, however, that the Company may not delay or suspend the Registration Statement on more
than two (2) occasions or for more than sixty (60) consecutive calendar days, or more than one hundred and twenty (120) total calendar
days, in each case during any twelve (12) month period. Upon receipt of any written notice from the Company of the happening of
any Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event the
Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were
made (in the case of the prospectus) not misleading, Subscriber agrees that (i) it will immediately discontinue offers and sales
of the Registrable Securities under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant
to Rule 144) until Subscriber receives copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare)
that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become
effective or unless otherwise notified by the Company that it may resume such offers and sales, and (ii) it will maintain the confidentiality
of any information included in such written notice delivered by the Company unless otherwise required by law or subpoena. Notwithstanding
anything to the contrary set forth herein, the Company shall not, when so advising Subscriber of a Suspension Event, provide Subscriber
with any material, nonpublic information regarding the Company (other than to the extent that providing notice to Subscriber of
the occurrence of a Suspension Event may itself constitute material, nonpublic information regarding the Company). If so directed
by the Company, Subscriber will deliver to the Company or, in Subscriber’s sole discretion destroy, all copies of the prospectus
covering the Registrable Securities in Subscriber’s possession; provided, however, that this obligation to
deliver or destroy all copies of the prospectus covering the Registrable Securities shall not apply (i) to the extent Subscriber
is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory or professional
requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically
on archival servers as a result of automatic data back-up.

 

(d) The Company
shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Subscriber (to the
extent a seller under the Registration Statement), the officers, directors, trustees, agents, partners, members, managers, stockholders,
affiliates, employees and investment advisers of each of them, each person who controls Subscriber (within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, trustees, agents, partners, members,
managers, stockholders, affiliates, employees and investment advisers of each such controlling person, to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
costs of preparation and investigation and reasonable attorneys’ fees) and expenses (collectively, “Losses”),
as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in the
Registration Statement, any prospectus included in the Registration Statement or any form of prospectus or in any amendment or
supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form
of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation
or alleged violation by the Company of the Securities Act, Exchange Act or any state securities law or any rule or regulation
thereunder, in connection with the performance of its obligations under this Section 6, except insofar as and to the extent, but
only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon
information regarding Subscriber furnished in writing to the Company by Subscriber expressly for use therein. The Company shall
notify Subscriber promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions
contemplated by this Section 6 of which the Company is aware. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of an indemnified party and shall survive the transfer of the Acquired Shares by Subscriber. 

 

(e) Subscriber shall, severally and not
jointly with any Other Subscriber, indemnify and hold harmless the Company, its directors, officers, agents and employees, each
person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and
the directors, officers, agents or employees of such controlling persons, to the fullest extent permitted by applicable law, from
and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement of a material fact
contained in any Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus, or in
any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus,
or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading to the
extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding Subscriber
furnished in writing to the Company by Subscriber expressly for use therein. In no event shall the liability of Subscriber under
this Section 6(e) be greater in amount than the dollar amount of the net proceeds received by Subscriber upon the sale of the Acquired
Shares giving rise to such indemnification obligation.

 

    12

     

    

 

(f) Any person
or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s
or entity’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying
party) and (B) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and
indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim
with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be
subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably
withheld, conditioned or delayed). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim
shall not be obligated to pay the fees and expenses of more than one counsel (in addition to local counsel) for all parties indemnified
by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of
interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying
party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which
cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the
terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified
party or which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect to such claim or litigation, and in no event shall the liability of Subscriber under
this Section 6(f) be greater in amount than the dollar amount of the net proceeds received by Subscriber upon the sale of the
Acquired Shares giving rise to such indemnification obligation. 

 

(g) If the indemnification provided under
this Section 6 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any
losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the
indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims,
damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party
and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue
or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates
to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s
relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable
by a party as a result of the losses or other liabilities referred to above shall be subject to the limitations set forth in this
Section 6 and deemed to include any legal or other fees, charges or expenses reasonably incurred by such party in connection with
any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution pursuant to this Section 6(g) from any person who was not guilty of such fraudulent misrepresentation.
Each indemnifying party’s obligation to make a contribution pursuant to this Section 6(g) shall be several, not joint.

 

7. Termination. This Subscription
Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder
shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such
date and time as the Merger Agreement is terminated in accordance with its terms, (b) upon the mutual written agreement of each
of the parties hereto to terminate this Subscription Agreement or (c) written notice by either party to the other party to terminate
this Subscription Agreement if the transactions contemplated by this Subscription Agreement are not consummated on or prior to
the Termination Date (as defined in the Merger Agreement, and, for the avoidance of doubt, giving effect to the permitted extension
thereof as set forth in the Merger Agreement); provided, that nothing herein will relieve any party from liability for any
willful breach hereof (including for the avoidance of doubt any party’s willful breach of its representations and warranties
hereunder) prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses,
liabilities or damages arising from such breach. The Company shall promptly notify Subscriber of the termination of the Merger
Agreement promptly after the termination of such Merger Agreement.

 

    13

     

    

 

8. Trust Account Waiver. Subscriber
acknowledges that the Company is a blank check company with the powers and privileges to effect a merger, asset acquisition, reorganization
or similar business combination involving the Company and one or more businesses or assets. Subscriber further acknowledges that,
as described in the Company’s prospectus relating to its initial public offering dated September 29, 2020 (the “Prospectus”)
available at www.sec.gov, substantially all of the Company’s assets consist of the cash proceeds of the Company’s initial
public offering and private placements of its securities, and substantially all of those proceeds have been deposited in a trust
account (the “Trust Account”) for the benefit of the Company, its public stockholders and the underwriters of
the Company’s initial public offering. Except with respect to interest earned on the funds held in the Trust Account that
may be released to the Company to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for the
purposes set forth in the Prospectus. For and in consideration of the Company entering into this Subscription Agreement, the receipt
and sufficiency of which are hereby acknowledged, Subscriber, on behalf of itself and its representatives, hereby irrevocably waives
any and all right, title and interest, or any claim of any kind they have or may have in the future arising out of this Subscription
Agreement, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account as a result
of, or arising out of, this Subscription Agreement. Notwithstanding anything else in this Section 8 to the contrary, nothing herein
shall be deemed to limit Subscriber’s right, title, interest or claim to the Trust Account by virtue of Subscriber’s
record or beneficial ownership of Class A Common Stock acquired by any means other than pursuant to this Subscription Agreement,
including but not limited to any redemption right with respect to any such securities of the Company.

 

9. Miscellaneous.

 

(a) Each party hereto acknowledges that
the other party hereto and others will rely on the acknowledgments, understandings, agreements, representations and warranties
contained in this Subscription Agreement. Prior to the Closing, each party hereto agrees to promptly notify the other party if
it becomes aware that any of the acknowledgments, understandings, agreements, representations and warranties of such party set
forth herein are no longer accurate in all material respects.

 

(b) Each of the Company and Subscriber
is entitled to rely upon this Subscription Agreement and each of the Company and Subscriber is irrevocably authorized to produce
this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry
with respect to the matters covered hereby.

 

(c) Neither this Subscription Agreement
nor any rights that may accrue to Subscriber hereunder (other than the Acquired Shares acquired hereunder, if any) may be transferred
or assigned. Neither this Subscription Agreement nor any rights that may accrue to the Company hereunder may be transferred or
assigned. Subscriber may transfer or assign all or a portion of its rights under this Subscription Agreement to an affiliate or
to any fund or account managed by the same investment manager as Subscriber, provided that no such assignment shall relieve
Subscriber of its obligations hereunder, and provided further that Subscriber shall provide notice to the Company upon such
transfer.

 

(d) All the agreements, representations
and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

(e) The Company may request from Subscriber
such additional information as the Company may deem reasonably necessary to evaluate the eligibility of Subscriber to acquire the
Acquired Shares, and Subscriber shall promptly provide such information as may be reasonably requested, to the extent readily available
and to the extent consistent with its internal policies and procedures, and provided that the Company agrees to keep confidential
any such information provided by Subscriber to the extent permitted by law.

 

(f) This Subscription Agreement may not
be modified, waived or terminated (except as set forth in Section 7) except by an instrument in writing, signed by the party against
whom enforcement of such modification, waiver, or termination is sought. Notwithstanding the foregoing, no modification or waiver
of this Subscription Agreement shall be effective unless and until consented to in writing by LCP Edge Intermediate, Inc.

 

    14

     

    

 

(g) This Subscription Agreement constitutes
the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and
oral, among the parties, with respect to the subject matter hereof. Except as otherwise set forth herein, this Subscription Agreement
shall not confer any rights or remedies upon any person other than the parties hereto, their respective successor and assigns;
provided, however, that LCP Edge Intermediate, Inc. is an express intended third party beneficiary of the last sentence of Section
9(f).

 

(h) Except as otherwise provided herein,
this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators,
successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments
contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives
and permitted assigns.

 

(i) If any provision of this Subscription
Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this
Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect. The parties
hereto shall execute and deliver all such further instruments and documents and take all such other actions as may reasonably be
required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained.

 

(j) This Subscription Agreement may be
executed and delivered in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by different parties
in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed
and delivered shall be construed together and shall constitute one and the same agreement.

 

(k) The parties
hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not
performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall
be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the
terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled
at law, in equity, in contract, in tort or otherwise. 

 

(l) Subscriber acknowledges that it is
not relying upon, and has not relied upon, any statement, representation or warranty made by any person other than the statements,
representations and warranties contained in this Subscription Agreement in making its investment or decision to invest in the Company.
Subscriber agrees that none of (i) any Other Subscriber pursuant to the Other Subscription Agreements (including the controlling
persons, members, officers, directors, partners, agents, or employees of any such other purchaser), (ii) the Placement Agent, its
respective affiliates or any of its or their respective affiliates’ control persons, officers, directors or employees, or
(iii) any other party to the Merger Agreement (other than LCP Edge Intermediate, Inc. following closing of the Transactions), including
any such party’s representatives, affiliates or any of its or their control persons, officers, directors or employees, that
is not a party hereto, shall be liable to Subscriber pursuant to this Subscription Agreement for any action heretofore or hereafter
taken or omitted to be taken by any of them in connection with the purchase of the Acquired Shares. On behalf of itself and its
affiliates, Subscriber releases the Placement Agent in respect of any losses, claims, damages, obligations, penalties, judgments,
awards, liabilities, costs, expenses or disbursements related to this Subscription Agreement or the transactions contemplated hereby.

 

(m) The parties hereto acknowledge and
agree that the Placement Agent is a third-party beneficiary of the representations and warranties of the parties contained in this
Subscription Agreement.

 

(n) Notices.
All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Subscription
Agreement shall be in writing and shall be deemed to have been given (i) when personally delivered, (ii) the business day following
the day on which the same has been delivered prepaid to a reputable national overnight air courier service, (iii) the third business
day following the day on which the same is sent by certified or registered mail, postage prepaid and (iv) when transmitted via
email to the email addresses set out below. Notices, demands and communications, in each case to the respective parties, shall
be sent to the applicable address set forth below, unless another address has been previously specified in writing:

 

(i) if
to Subscriber, to such address or addresses set forth on the signature page hereto;

 

(ii) if
to the Company, to: 

 

Vesper Healthcare Acquisition
Corp.

1819 West Avenue, Bay 2

Miami Beach, FL 33139

Attention: Brenton L. Saunders and Manisha Narasimhan

Email: Brent.Saunders@vesperhealth.com and

Manisha.Narasimhan@vesperhealth.com

 

    15

     

    

  

with a copy (which
shall not constitute notice) to:

 

Wachtell, Lipton, Rosen &
Katz

51 West 52nd Street

New York, NY 10019

Attention: Andrew R. Brownstein, Igor Kirman and DongJu Song

Email: ARBrownstein@wlrk.com, IKirman@wlrk.com and DSong@wlrk.com

 

(iii) if
to the Placement Agent, to: 

 

Goldman Sachs & Co. LLC

200 West Street

New York, NY 10282

Attn: Olympia McNerney

Telephone: 212-357-8838

Email: Olympia.mcnerney@gs.com

 

Goldman Sachs & Co. LLC

200 West Street

New York, NY 10282

Attn: Paige Weiser

Telephone: 212-902-0458

Email: paige.weiser@gs.com

 

(o) THIS SUBSCRIPTION AGREEMENT SHALL
BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS
OF LAWS THAT WOULD OTHERWISE REQUIRE THE APPLICATION OF THE LAW OF ANY OTHER STATE. EACH PARTY HERETO HEREBY WAIVES ANY RIGHT TO
A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS SUBSCRIPTION AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(p) The Company shall, by 9:00 a.m.,
New York City time, on the first business day immediately following the execution and delivery of this Subscription Agreement,
issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”)
disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements, the Merger Agreement,
the Transactions and any other material, nonpublic information that the Company has provided to Subscriber at any time prior to
the filing of the Disclosure Document. Upon the issuance of the Disclosure Document, to the Company’s knowledge, Subscriber
shall not be in possession of any material, nonpublic information received from the Company or any of its officers, directors
or employees or agents (including the Placement Agent) and Subscriber shall no longer be subject to any confidentiality or similar
obligations under any current agreement, whether written or oral with the Company, the Placement Agent or any of their respective
affiliates. Notwithstanding anything in this Subscription Agreement to the contrary, the Company shall not publicly disclose the
name of Subscriber or any of its affiliates or investment advisers, or include the name of Subscriber or any of its affiliates
or investment advisers in any press release or in any filing with the SEC or any regulatory agency or trading market, in either
case in connection with this Subscription Agreement or the transactions contemplated hereby, without the prior written consent
of Subscriber, except to the extent such disclosure is required by applicable law, rule, regulation, SEC or stock exchange requirement
or at the request of any governmental or regulatory agency or as required by legal process, in which case the Company shall provide
Subscriber with written notice of such disclosure permitted under this Section 9(p) prior to such disclosure to the extent permitted
by law. 

 

    16

     

    

 

IN WITNESS WHEREOF, each of the
Company and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.

 

	 	VESPER HEALTHCARE ACQUISITION CORP.

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

Date: December 8, 2020

 

     

     

    

 

SUBSCRIBER:

 

	Signature of Subscriber:	 	Signature of Joint Subscriber, if applicable:

 

	By:
    	 	 	By:
    	
	 	Name: 	 	 	Name: 
	 	Title: 	 	 	Title: 

 

	Date:  December
    8, 2020	 	 
	 	 	 
	Name of Subscriber:	 	Name of Joint Subscriber, if applicable:
	 	 	 
	(Please print.  Please indicate name
    and capacity of person signing above)	 	(Please Print.  Please indicate name
    and capacity of person signing above)
	 	 	 
	Name in which shares are to be
    registered (if different):	 	 
	 	 	 
	Email Address:	 	 
	 	 	 
	If there are joint investors, please check one:	 	 
	 	 	 
	☐  Joint Tenants with Rights
    of Survivorship	 	 
	☐  Tenants-in-Common	 	 
	☐  Community Property	 	 
	 	 	 
	Subscriber’s EIN:	 	Joint Subscriber’s EIN:
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:	 	Attn:
	 	 	 
	Telephone No.:	 	Telephone No.:
	 	 	 
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Aggregate Number of Acquired Shares subscribed
    for: __________	 	 
	 	 	 
	Aggregate Purchase Price:  $ _________	 	 

 

	You must pay the Purchase Price by wire transfer of United States dollars in immediately available funds to the account specified by the Company in the Closing Notice.

 

     

     

    

 

SCHEDULE A

 

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

This Schedule must be completed by
Subscriber and forms a part of the Subscription Agreement to which it is attached. Capitalized terms used and not otherwise defined
in this Schedule have the meanings given to them in the Subscription Agreement. Subscriber must check the applicable box in either
Part A or Part B below and the applicable box in Part C below.

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

(Please check the applicable subparagraphs):

 

		☐	We are a “qualified institutional buyer” (as
defined in Rule 144A under the Securities Act (a “QIB”)).

 

		☐	We are subscribing for the Acquired Shares as a fiduciary
or agent for one or more investor accounts, and each owner of such account is a QIB.

 

***OR***

 

		B.	ACCREDITED INVESTOR STATUS

 

(Please check the applicable subparagraphs):

 

		☐	We are an institutional “accredited investor”
(within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act or an entity in which all of the equity holders
are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate
box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

		☐	We are an “accredited investor” (within the
meaning of Rule 501(a)(12) under the Securities Act) with assets under management in excess of $50,000,000, and have marked and
initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

		☐	We are not a natural person.

 

***AND***

 

		C.	AFFILIATE STATUS

 

(Please check the applicable box)

 

SUBSCRIBER:

 

		☐	is:

 

		☐	is not:

 

an “affiliate”
(as defined in Rule 144 under the Securities Act) of the Company or acting on behalf of an affiliate of the Company.

 

    Schedule A-1

     

    

 

This page should be completed by Subscriber

and constitutes a part of the Subscription Agreement.

 

Rule 501(a)(1), (2), (3) or (7), in relevant part, states that
an institutional “accredited investor” shall mean any person who comes within any of the below listed categories, or
who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to
that person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply
to Subscriber and under which Subscriber accordingly qualifies as an “accredited investor.”

 

		☐	Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small
business investment company;

 

		☐	Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or
its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

		☐	Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance
company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

		☐	Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business
trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of
$5,000,000;

 

		☐	Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by
a sophisticated person;

 

		☐	A “family office” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act with assets under management
in excess of $50,000,000 that is not formed for the specific purpose of acquiring the securities offered and whose prospective
investment is directed by a person who has such knowledge and experience in financial and business matters that such family office
is capable of evaluating the merits and risks of the prospective investment; or

 

		☐	Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

 

Schedule A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]